Jeff Hutchins, PhD, discusses current clinical trials that are investigating whether some patients with non-small cell lung cancer may qualify for an immune-oncology therapy treatment regimen that is...
Ryan Ungaro, MD, of the Icahn School of Medicine at Mt. Sinai in New York, gives a recap of his presentation on treat-to-target in IBD from the virtual Advances in Inflammatory Bowel Disease 2020 regional...